Teva Pharmaceuticals agreed to pay more than $200 million in fines and divest a key generic drug treating cholesterol to settle price-fixing charges from the US Department of Justice, the agency ...

Teva Pharmaceutical Industries Ltd has agreed to pay $450 million to resolve allegations it used charities that help cover Medicare patients' out-of-pocket drug costs as a means to pay kickbacks ...

Teva maintained that it did not market its opioids to doctors. One of Teva’s initial settlement offers, in 2019, consisted almost entirely of medications, along with a small amount of cash.